1. Игнатов Ю.Д., Кукес В.Г., Мазуров В.И. Клиническая фармакология нестероидных противовоспалительных средств. М., 2010.
2. Бадокин В.В. Нестероидные противовоспалительные препараты в локальной терапии ревматических заболеваний. Лечащий врач. 2010; 4.
3. Красносельских Т.В., Мошкалова И.А., Михеев Г.Н. Наружная терапия заболеваний кожи. Под ред. Е.В.Соколовского. СПб.: СОТИС, 1999.
4. Mason L, Moore R, Edwards J et al. Topical NSAIDs for acute pain: a metaanalysis. BMC Fam Pract 2004; 5: 10.
5. Mason L, Moore R, Edwards J et al. Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet Dis 2004; 5: 283.
6. Moore R, Tramer M, Carroll D et al. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 1998; 316: 333–8.
7. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000; 9 (43): 1905–15.
8. NICE. Osteoarthritis. The care and management of osteoarthritis in adults. NICE Clinical Guidelines 2008.
9. Zhang W, Moskowitz RW, Nuki MB et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008; 16: 137–62.
10. Jordan K, Arden N, Doherty M et al. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the standing committee for international clinical studies including therapeutic trials (ESCISIT). Ann Rheum Dis 2003; 62: 1145–55.
11. Lin J, Zhang W, Jones A, Doherty M. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ 2004; 329: 324.
12. Green C., Buchbinder R., Barnsli l et al. NSAID Cochrane Database Syst Rev CD 003683.
13. Rovensky J, Micekova D, Gubzova Z et al. Treatment of knee osteoarthritis with a topical non-steroidal antiinflammatory drug: results of a randomized, double-blind, placebo-controlled study on the efficacy and safety of a 5% ibuprofen cream. Drugs Under Exp Clin Res. 2001; 27: 209–21.
14. Grace D, Rogers J, Skeith K et al. Topical diclofenac versus placebo: a double blind, randomized clinical trial in patients with osteoarthritis of the knee. J Rheumatol 1999; 26: 2659–63.
15. van Haselen RAPA, Fisher G. A randomized controlled trial comparing topical piroxicam gel with a homeopathic gel in osteoarthritis of the knee and Oxf J Med Rheumatol. 7 (39): 714–19.
16. Bookman AAM, Williams KSA, Shainhouse JZ. Med As J CMAJ 2004; 171: 333–8.
17. Lin J, Zhang W, Jones A, Doherty M. Efficacy of topical NSAIDs in the treatment of osteoarthritis: a meta-analysis of randomized, controlled trials. Chin J Evid Based Med 2005; 5: 667–749.
18. Henry D, Lim L, Garcia Rodriguez L et al. Variability in risk of gastrointestinal complications withindividual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996; 312: 1563–6.
19. Ong CKS, Tan CH, Seymour RA. An evidence-based update on non-steroidal anti-inflammatory drugs. Clin Med Res 2007; 5: 19–34.
20. Zacher J, Altman R, Bellamy N et al. Topical diclofenac and its role in pain and inflammation: an evidence–based review. Curr Med Res Opin 2008; 24: 925–50.
21. Hindsen M, Zimerson E, Bruze M. Photoallergic contact dermatitis from ketoprofen in southern Sweden. Contact Dermatitis 2006; 54: 150–7.
22. Matthieu L, Meulman L, van Hecke E et al. Contact and photocontact allergy to ketoprofen. The Belgian experience. Contact Dermatitis 2004; 50: 238–41.
23. Diaz RL, Gardeazabal J, Manrique P et al. Greater allergenicity of topical ketoprofen in contact dermatitis confirmed by use. Contact Dermatitis 2006; 54: 239–43.
24. Leonard F, Adamski H, Bonnevalle A et al. The prospective multicenter study on standard photopatch tests by the French Society of Photodermatology from 1991–2001. Ann Dermatol Venereol 2005; 132: 313–20.
25. Veyrac G, Paulin M, Milpied B et al. Results of a French nationwide survey of cutaneous side effects of ketoprofen gel reported between September 1996 and August 2000. Therapie 2002; 57: 55–64.
26. el-Hadidi T, el-Garf A. Double-blind study comparing the use of Voltaren Emulgel versus regular gel during ultrasonic sessions in the treatment of localized traumatic and rheumatic painful conditions. Int Med Res 1991; 19: 219–27.
27. Radermacher J, Jentsch D, Scholl MA et al. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmac 1991; 31: 537–41.
28. Schapira D, Linn S, Scharf Y. A placebo-controlled evaluation of diclofenac diethylamine salt in the treatment of lateral epicondylitis of the elbow. Curr Ther Res 1991; 49: 162–8.
29. Schermer R. Topical therapy for sprains of the ankle joint. A double–blind study of the efficacy of diclofenac–diethylammonium in an emulsion-gel. Wehrmed Mschr 1991; 9: 415–19.
30. Diebschlag W. Diclofenac in blunt traumatic ankle joint swelling. Volumetric monitoring in a placebo controlled double-blind trial. Fortsch Med 1986; 104: 437–40.
31. Taylor RS, Fotopoulos G, Maibach H. Safety profile of topical diclofenac: a meta–analysis of blinded, randomized, controlled trials in musculoskeletal conditions. Curr Med Res & Opin 2011; 3 (27): 605–22.

А.В.Амелин, П.О.Амелина 

СПбГМУ им. И.П.Павлова